Emerging Therapeutic Targets for Metabolic Syndrome: Lessons from Animal Models

被引:3
作者
Singh, Himadri [1 ]
Pragasam, Samuel Joshua [1 ]
Venkatesan, Vijayalakshmi [1 ]
机构
[1] Natl Inst Nutr, Stem Cell Res Biochem, Hyderabad 500007, Andhra Pradesh, India
关键词
Obesity; diabetes; metabolic syndrome; inflammation; NCDs; animal models; MESENCHYMAL STEM-CELLS; GENE-EXPRESSION; RAT MODEL; GLUCOSE-TOLERANCE; INDUCED OBESITY; WEIGHT-LOSS; FAILURE; DIFFERENTIATION; CONTRIBUTES; DYSFUNCTION;
D O I
10.2174/1871530319666181130142642
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Metabolic syndrome is a cluster of medical conditions that synergistically increase the risk of heart diseases and diabetes. The current treatment strategy for metabolic syndrome focuses on treating its individual components. A highly effective agent for metabolic syndrome has yet to he developed. To develop a target for metabolic syndrome, the mechanism encompassing different organs - nervous system, pancreas, skeletal muscle, liver and adipose tissue - needs to be understood. Many animal models have been developed to understand the pathophysiology of metabolic syndrome. Promising molecular targets have emerged while characterizing these animals. Modulating these targets is expected to treat some components of metabolic syndrome. Objective: To discuss the emerging molecular targets in an animal model of metabolic syndrome. Methods: A literature search was performed for the retrieval of relevant articles. Conclusion: Multiple genes/pathways that play important role in the development of Metabolic Syndrome are discussed.
引用
收藏
页码:481 / 489
页数:9
相关论文
共 91 条
  • [1] Metabolic syndrome: do clinical criteria identify similar individuals among overweight premenopausal women?
    Alhassan, Sofiya
    Kiazand, Alexandre
    Balise, Raymond R.
    King, Abby C.
    Reaven, Gerald M.
    Gardner, Christopher D.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (01): : 49 - 56
  • [2] Key transcription factors in the differentiation of mesenchymal stem cells
    Almalki, Sami G.
    Agrawal, Devendra K.
    [J]. DIFFERENTIATION, 2016, 92 (1-2) : 41 - 51
  • [3] Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198
  • [4] The Relationship between Metabolic Syndrome and Pulmonary Function
    Bae, Myoung-Sook
    Han, Jee-Hae
    Kim, Jung-Hwan
    Kim, Yeong-Ju
    Lee, Kyung-Jin
    Kwon, Kil-Young
    [J]. KOREAN JOURNAL OF FAMILY MEDICINE, 2012, 33 (02): : 70 - 78
  • [5] Metabolic Syndrome and the Lung
    Baffi, Cynthia W.
    Wood, Lisa
    Winnica, Daniel
    Strollo, Patrick J., Jr.
    Gladwin, Mark T.
    Que, Loretta G.
    Holguin, Fernando
    [J]. CHEST, 2016, 149 (06) : 1525 - 1534
  • [6] Bansal VS, 2013, INDIAN J MED RES, V137, P695
  • [7] Preclinical models for obesity research
    Barrett, Perry
    Mercer, Julian G.
    Morgan, Peter J.
    [J]. DISEASE MODELS & MECHANISMS, 2016, 9 (11) : 1245 - 1255
  • [8] Prevalence and Trends of Metabolic Syndrome in the Adult U.S. Population, 1999-2010
    Beltran-Sanchez, Hiram
    Harhay, Michael O.
    Harhay, Meera M.
    McElligott, Sean
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (08) : 697 - 703
  • [9] The role of mitochondria in osteoarthritis
    Blanco, Francisco J.
    Rego, Ignacio
    Ruiz-Romero, Cristina
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2011, 7 (03) : 161 - 169
  • [10] Increased interleukin (IL)-1β messenger ribonucleic acid expression in β-cells of individuals with type 2 diabetes and regulation of IL-1β in human islets by glucose and autostimulation
    Boni-Schnetzler, Marianne
    Thorne, Jeffrey
    Parnaud, Geraldine
    Marselli, Lorella
    Ehses, Jan A.
    Kerr-Conte, Julie
    Pattou, Francois
    Halban, Philippe A.
    Weir, Gordon C.
    Donath, Marc Y.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10) : 4065 - 4074